Several in vitro assays have been developed to evaluate the gastrointestinal absorption of compounds. Our aim was to compare 3 of these methods: 1) the bio-mimetic artificial membrane permeability assay (BAMPA) method, which offers a highthroughput, noncellular approach to the measurement of passive transport; 2) the traditional Caco-2 cell assay, the use of which as a high-throughput tool is limited by the long cell differentiation time (21 days); and 3) The BioCoat™ high-throughput screening Caco-2 Assay System, which reduces Caco-2 cell differentiation to 3 days. The transport of known compounds (such as cephalexin, propranolol, or chlorothiazide) was studied at pH 7.4 and 6.5 in BAMPA and both Caco-2 cell models. Permeability data obtained was correlated to known values of human absorption. Best correlations (r = 0.9) were obtained at pH 6.5 for BAMPA and at pH 7.4 for the Caco-2 cells grown for 21 days. The Caco-2 BioCoat™ HTS Caco-2 Assay System does not seem to be adequate for the prediction of absorption. The overall results indicate that BAMPA and the 21-day Caco-2 system can be complementary for an accurate prediction of human intestinal absorption. (Journal of Biomolecular Screening 2004:598-606) Key words: BAMPA, bioavailability, Caco-2, permeability A LTHOUGH BIOLOGICAL EFFICACY is the key issue during the discovery process of active compounds, other factors such as bioavailability are equally important when the action of the ingredient is not limited to the gastrointestinal tract. An efficacious compound must be sufficiently bioavailable to perform its expected activity. The gastrointestinal absorption of an orally administered compound is one of the key factors for its bioavailability. Because absorption potential has become a more important criterion in the discovery process, there is a need for reliable screening methods to assess for compound permeability.
1Intestinal absorption screening assays should be highly predictive, fast, reliable, cost-effective, and require a small amount of compound.
2,3Current approaches include physicochemical models, in silico computational models, in vitro models (cell and tissue based), in situ models of intestinal perfusion, and in vivo animal models.
1The intestinal absorption of a compound depends on 2 major parameters: 1) permeability across the epithelial mucosa and 2) gastrointestinal transit. Because gastrointestinal transit can be evaluated only in vivo, all in vitro systems can determine only mucosal permeability.The main barrier for the absorption of a compound is formed by the intestinal epithelium, and several routes can be followed to cross this barrier. The passive transcellular pathway involves the movement of solute molecules across the apical membrane, through the cytoplasm, and across the basolateral membrane. This is the predominant route for hydrophobic compounds. Another passive route is via the tight junctions between the enterocytes: the paracellular pathway. Small hydrophilic compounds are mostly transported via the paracellular route...